More recently, the aberrant expression of P-cadherin (CDH3) and cadherin-11 (CDH11) have also been described in the context of different types of cancer such as in malignant melanoma, breast, gastric, lung, colorectal, and pancreatic cancer [4,5,6,7,8,9]. This evidence concerns the gene CDH3 and familial pancreatic carcinoma.